Motiva® breast implants have been used worldwide since 2010, were approved by the FDA in September, 2024 and then first became available for use in the United States. These 6th generation highly cohesive, viscoelastic silicone gel 100% filled implants provide a soft, natural feel with the movement of natural breast tissue.
Motiva® implants have a 4 micron smooth silk surface outer shell, called a TrueMonobloc® shell, which can be considered a modification of the outer shell on traditional smooth silicone breast implants. The outer shell on these traditional smooth implants have an average roughness of approximately 1 micron. This unique TrueMonobloc® shell is created by a next-generation gel-bonding technology which unifies the implant’s shell, gel, and patch into one single, cohesive unit. By integrating all of the components of the implant into a single structure, the implant’s flexibility and strength are increased. This not only allows for natural movement, but improves the durability of these implants with a less than 1% rupture rate, and easier implant placement through smaller incisions.
The TrueMonobloc® design also provides enhanced biocompatibility and optimized immune response of the patient’s body to the implant, promoting a low inflammatory response, low bacterial attachment, and low friction. These factors contribute to a softer, thinner, translucent capsule, the collagen-based scar tissue the patient’s body always forms around every breast implant as a normal part of the body’s healing process. Motiva®’s rate of capsular contracture (when this scar tissue around the implant tightens, becomes hard and sometimes painful) is less than 1%, far lower than that obtained with traditional implants currently on the market. Motiva® implants can be a great tool to prevent initial and recurrent capsular contracture.
Motiva® Implant Types
There are two types of Motiva® implants. Motiva Round® Implants have a somewhat greater viscosity with slightly more firmness while distributing volume equally throughout the implant. These are designed for the patient who desires a more voluptuous look with more fullness in the upper pole of the breast and longer-lasting projection.
The Motiva Ergonomix® Implants (which embody the science of ergonomics) have roughly 10% less viscosity than the Motiva Round® Implants. Their ergonomic design creates a responsive, slightly softer breast implant that gives the natural feel and movement of breast tissue, with a more anatomic “tear-drop” shape, even when lying down or moving. The Ergonomix® design is ideal for those seeking a breast implant that offers a natural look in all positions, allowing the implants to adapt to body movements.
Both of these Motiva® gel types provide more projection than existing silicone implants on the market. During the patient’s consultation with Dr. Parker, they will be able to hold and feel both of these gel types and discuss which is best for them. You can read more about the Motiva SmoothSilk Ergonomix® and Round® breast implants on the Motiva® Breast Implant page.
Motiva® Implant Profiles
In addition to the two types of gel used to fill these implants, there are 3 types of projection, or profiles, for each gel, allowing for a customized approach to the aesthetic goals of every patient. The Full implant provides the greatest amount of projection, ideal for patients who desire a noticeable, natural contour and a more enhanced appearance, The Demi implant delivers a moderate amount of projection, ideal for patients who desire a natural enhancement. The Mini implant creates the least amount of fullness and projection for a more subtle, natural look. During the patient’s consultation with Dr. Parker, they will undergo a Sizing Session during which time they will try on various implants types and projections to see what is best for them.
Dr. Parker will insert these implants in a subfascial or dual plane location based on the individual patient’s desires and anatomy, all of which are carefully discussed at the time of consultation.
Benefits of Motiva® Implants
Motiva® implants’ unique design allow Dr. Parker to place these implants in the subfascial plane, whereby the implant is inserted beneath the pectoralis fascia, a thin layer of connective tissue covering the pectoralis major muscle. The composition of these implants in this anatomic location allows for a natural slope to the breast, yet minimizes implant rippling. These patients enjoy a somewhat quicker and even easier recovery.
For patients with thinner tissue, Dr. Parker will often place the implants in a dual plane location, that is, the upper portion of the implant is covered by the pectoralis major muscle and the lower portion by the patient’s breast tissue.
Small breasts, otherwise known as “Ballerina Breasts,” “yoga breasts,” or “petite breast augmentation” have become popular in recent years. These terms describe the natural, elegant breast shape with a soft, subtle contour and gentle profile inspired by a ballerina’s grace; their natural, graceful, fluid, and poised movements. Motiva®’s implants, particularly their Ergonomix® implants, by virtue of their design and TrueMonobloc® construction, lend themselves very well to achieving this aesthetic ideal. Their composition creates a teardrop-shaped ballerina-breast effect, characterized by a soft, natural-looking shape with a gentle teardrop form that adjusts with body movement.
Motiva® implants in the US, showed a 97% patient satisfaction rate, 99% surgeon satisfaction rate…
Both SmoothSilk Round® implants and Ergonomix® implants create ballerina breasts, either round-shaped or teardrop-shaped ballerina breasts, respectively. In particular, Ergonomix® implants create a teardrop-shaped ballerina-breast effect, typified by a soft, natural-looking shape with a gentle teardrop form that adapts to and complements the patient’s natural body movements. The size implants used for these patients are most commonly in the range of 150 to 275 cc. This procedure particularly appeals to patients whose aesthetic ideal is an athletic, toned physique with a naturally contoured figure.
The 3 year results, reported in November, 2024, from the still ongoing 10 year clinical trial of Motiva® implants in the US, showed a 97% patient satisfaction rate, 99% surgeon satisfaction rate as well as a rate of capsular contracture and rupture, both of which were less than 1%. These impressive statistics, as well as conversations with colleagues of his around the country, have led Dr. Parker to offer Motiva® implants to his patients.
Leave a Reply